Zhou S - Search Results

1

Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.

Zhu J, Zheng H, Ge C, Lin H, Yu K, Wu L, Li D, Zhou S, Tang W, Wang Q, Zhang X, Jin X, Xu X, Du J, Fu J. Zhu J, et al. Among authors: zhou s. Clin Breast Cancer. 2022 Apr;22(3):e296-e309. doi: 10.1016/j.clbc.2021.08.008. Epub 2021 Aug 31. Clin Breast Cancer. 2022. PMID: 34627728

2

Impact of old age on resectable colorectal cancer outcomes.

Fu J, Ruan H, Zheng H, Cai C, Zhou S, Wang Q, Chen W, Fu W, Du J. Fu J, et al. Among authors: zhou s. PeerJ. 2019 Feb 15;7:e6350. doi: 10.7717/peerj.6350. eCollection 2019. PeerJ. 2019. PMID: 30792941 Free PMC article.

3

p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report.

Zheng H, Zhou S, Tang W, Wang Q, Zhang X, Jin X, Yuan Y, Fu J. Zheng H, et al. Among authors: zhou s. BMC Neurol. 2020 Mar 4;20(1):76. doi: 10.1186/s12883-020-01659-7. BMC Neurol. 2020. PMID: 32126984 Free PMC article.

4

The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?

Lin H, Zheng H, Ge C, Wang Q, Tang W, Zhang X, Zhou S, Jin X, Xu X, Du J, Fu J. Lin H, et al. Among authors: zhou s. Clin Breast Cancer. 2020 Dec;20(6):503-510. doi: 10.1016/j.clbc.2020.05.012. Epub 2020 May 27. Clin Breast Cancer. 2020. PMID: 32653474

5

Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.

Chen Y, Tu J, Zhou S, Fu J, Wang Q. Chen Y, et al. Among authors: zhou s. Int J Colorectal Dis. 2021 Apr;36(4):745-756. doi: 10.1007/s00384-020-03809-2. Epub 2021 Jan 7. Int J Colorectal Dis. 2021. PMID: 33415449

6

A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation.

Zhou S, Tang W, Wang Q, Zhang X, Jin X, Xu X, Fu J. Zhou S, et al. Onco Targets Ther. 2021 Feb 11;14:989-993. doi: 10.2147/OTT.S287064. eCollection 2021. Onco Targets Ther. 2021. PMID: 33603403 Free PMC article.

7

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer.

Zheng H, Ge C, Lin H, Wu L, Wang Q, Zhou S, Tang W, Zhang X, Jin X, Xu X, Hong Z, Fu J, Du J. Zheng H, et al. Among authors: zhou s. Int J Clin Oncol. 2022 Jul;27(7):1145-1153. doi: 10.1007/s10147-022-02158-0. Epub 2022 Apr 10. Int J Clin Oncol. 2022. PMID: 35397755

8

An R-Based Landscape Validation of a Competing Risk Model.

Lin H, Zheng H, Ge C, Ling L, Yin R, Wang Q, Zhang X, Zhou S, Jin X, Xu X, Fu J. Lin H, et al. Among authors: zhou s. J Vis Exp. 2022 Sep 16;(187). doi: 10.3791/64018. J Vis Exp. 2022. PMID: 36190285

9

A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors.

Song B, Zhou S, Li C, Zheng H, Zhang X, Jin X, Fu J, Hu H. Song B, et al. Among authors: zhou s. Int J Gen Med. 2022 Nov 1;15:8003-8015. doi: 10.2147/IJGM.S383349. eCollection 2022. Int J Gen Med. 2022. PMID: 36345528 Free PMC article.

10

The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.

Zheng H, Ge C, Lin H, Zhou S, Tang W, Wang Q, Zhang X, Jin X, Xu X, Du J, Fu J. Zheng H, et al. Among authors: zhou s. PLoS One. 2023 Jan 18;18(1):e0280474. doi: 10.1371/journal.pone.0280474. eCollection 2023. PLoS One. 2023. PMID: 36652446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,607 results

Search Page

Filters